M1 Kliniken AG
XETRA:M12
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (8.3), the stock would be worth €17.9 (10% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 7.5 | €16.2 |
0%
|
| 3-Year Average | 8.3 | €17.9 |
+10%
|
| 5-Year Average | 7.4 | €16.11 |
-1%
|
| Industry Average | 8.9 | €19.33 |
+19%
|
| Country Average | 9 | €19.52 |
+21%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
€261m
|
/ |
Jul 2025
€35.4m
|
= |
|
|
€261m
|
/ |
Dec 2025
€36.4m
|
= |
|
|
€261m
|
/ |
Dec 2026
€40.4m
|
= |
|
|
€261m
|
/ |
Dec 2027
€43.4m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| DE |
|
M1 Kliniken AG
XETRA:M12
|
304.2m EUR | 7.5 | 17.3 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
98.7B USD | 8.9 | 14.5 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 31.9 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.8B ZAR | 9.4 | 14.2 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
78.2B MYR | 15.3 | 37.2 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.8B ZAR | 18.2 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
83.5B BRL | 7.7 | 17.9 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.7B USD | 5.6 | 11.2 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
97.1B CNY | 21.4 | 30.2 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 29.8 | 61.6 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
10.6B USD | 5.6 | 7.2 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.2 |
| Median | 9 |
| 70th Percentile | 13.6 |
| Max | 6 112.6 |
Other Multiples
M1 Kliniken AG
Glance View
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
